These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6327190)

  • 41. Menopausal hot flushes: a double blind comparison of placebo, ethinyl oestradiol and norgestrel.
    Dennerstein L; Burrows GD; Hyman G; Wood C
    Br J Obstet Gynaecol; 1978 Nov; 85(11):852-6. PubMed ID: 363136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-endorphin levels during the climacteric period.
    Schurz B; Wimmer-Greinecker G; Metka M; Heytmanek G; Egarter C; Knogler W
    Maturitas; 1988 May; 10(1):45-50. PubMed ID: 2840557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.
    Montemurro D; Rossi GP
    J Endocrinol Invest; 2006; 29(7):650-2. PubMed ID: 16957415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
    Pinkerton JV; Utian WH; Constantine GD; Olivier S; Pickar JH
    Menopause; 2009; 16(6):1116-24. PubMed ID: 19546826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints.
    Cullberg G; Knutsson F; Mattsson LA
    Maturitas; 1984 Jul; 6(1):55-63. PubMed ID: 6088950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time to transient and stable reductions in hot flush frequency in postmenopausal women using conjugated estrogens/bazedoxifene.
    Pinkerton JV; Bushmakin AG; Abraham L; Komm BS; Bobula J
    Menopause; 2017 Sep; 24(9):1011-1016. PubMed ID: 28463874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of Agreal in the treatment of the menopause].
    Marais C
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):156-62. PubMed ID: 3992113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The beta-endorphin level in climacteric women].
    Schurz B; Egarter C; Huber J; Wimmer-Greinecker G; Weindlmayer-Goettl M; Metka M
    Zentralbl Gynakol; 1988; 110(22):1428-32. PubMed ID: 2851901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Replacement estrogen therapy for menopausal vasomotor flushes. Comparison of quinestrol and conjugated estrogens.
    Baumgardner SB; Condrea H; Daane TA; Dorsey JH; Jurow HN; Shively JP; Wachsman M; Wharton LR; Zibel MJ
    Obstet Gynecol; 1978 Apr; 51(4):445-52. PubMed ID: 208034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is oestrogen therapy effective in the treatment of menopausal depression?
    Coope J
    J R Coll Gen Pract; 1981 Mar; 31(224):134-40. PubMed ID: 6268783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies.
    Poller L; Thomson JM; Coope J
    Br J Obstet Gynaecol; 1980 Aug; 87(8):718-25. PubMed ID: 7000169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
    Gerdes LC; Sonnendecker EW; Polakow ES
    Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of early menopause. A report of 2 cases].
    Gicquel A
    Sem Hop; 1983 Jan; 59(1):47-8. PubMed ID: 6297087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Veralipride: treatment of climacteric disorders].
    Stockmann R
    Rev Fr Gynecol Obstet; 1985 Jun; 80(6 Pt 2):495-9. PubMed ID: 4081505
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flushes in the surgical menopause.
    Sherwin BB; Gelfand MM
    Am J Obstet Gynecol; 1984 Mar; 148(5):552-7. PubMed ID: 6367474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of menopausal hot flushes by methyldopa. A double blind crossover trial.
    Nesheim BI; Saetre T
    Eur J Clin Pharmacol; 1981; 20(6):413-6. PubMed ID: 7026262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of Menorest in two positive-controlled studies.
    Pornel B
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S35-7. PubMed ID: 8732472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soy germ extract alleviates menopausal hot flushes: placebo-controlled double-blind trial.
    Imhof M; Gocan A; Imhof M; Schmidt M
    Eur J Clin Nutr; 2018 Jul; 72(7):961-970. PubMed ID: 29849181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
    Dargent D; Dumont M; Malinas Y
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):171-3. PubMed ID: 3992114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The menopause. Vasomotor flushing: physiopathology and treatment].
    Uzan S; Salat-Baroux J
    Rev Fr Gynecol Obstet; 1986 Sep; 81(8):407-12. PubMed ID: 2876487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.